Dole Europe Features Its Grapes Business and Announces Investments in the Production of Early Grapes in South Africa at the 2014 Fruit Logistica

At the 2014 Fruit Logistica in Berlin on Feb 5 to 7th, Dole Europe will be highlighting its projects and achievements in the grape category and announcing the potential acquisition of a controlling share in an early grape farm in South Africa, its first direct investment in fruit production in the country. Fruit Care Services (Pty) Ltd., one of Dole Europes subsidiaries located in South Africa, has recently signed a Memorandum of Understanding with a view to purchasing Rekopane, a 600-hectare farm located on the banks of the Orange River, 30km from the South African town of Upington.

Otsuka Receives Opinion from CHMP on Delamanid

Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for delamanid for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB) in combination with an optimised background regimen (OBR) according to WHO guidelines in patients. The CHMP considered that the duration of treatment (two months) in the Phase IIb randomised controlled trial (Trial 204) was too short to establish the effectiveness of delamanid in treating tuberculosis when added to other anti-tuberculosis medicines.